Félix Augusto Rey

Title: Innovations by Félix Augusto Rey

Introduction

Félix Augusto Rey is a prominent inventor based in Paris, France. He has made significant contributions to the field of virology, particularly in the development of vaccines against various viral infections. With a total of 2 patents, his work focuses on stabilizing viral proteins to enhance vaccine efficacy.

Latest Patents

One of his latest patents is titled "Stabilized recombinant hantaviral spike proteins comprising mutations in Gc." This invention describes the engineering of hantavirus spike proteins with modifications to stabilize heterodimer and homodimer contacts. The goal is to use these proteins as immunogens in next-generation vaccine design. The spike proteins are covalently stabilized by disulphide inter-chain bonds and can be utilized in various applications, including virus-like particles and recombinant viruses.

Another significant patent is "Neutralising antibody against dengue for use in a method of prevention and/or treatment of zika infection." This patent involves a stabilized recombinant flavivirus Envelope Dimer Epitope (EDE) for vaccinating individuals against flaviviruses. The EDE is designed to be covalently stabilized and can be used in methods for preventing or treating infections caused by Zika and dengue viruses.

Career Highlights

Félix has worked with esteemed organizations such as Institut Pasteur and Fundación Ciencia Para La Vida. His research has been pivotal in advancing our understanding of viral mechanisms and developing effective vaccines.

Collaborations

Throughout his career, Félix has collaborated with notable colleagues, including Nicole Tischler and Eduardo Andrés Bignon Silva. These partnerships have contributed to the success of his research and innovations.

Conclusion

Félix Augusto Rey's contributions to virology and vaccine development are noteworthy. His innovative patents reflect his commitment to advancing public health through scientific research.